View Past PerformanceFluroTech 대차대조표 건전성재무 건전성 기준 점검 1/6FluroTech 의 총 주주 지분은 CA$-302.4K 이고 총 부채는 CA$0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 CA$128.7K 및 CA$431.1K 입니다.핵심 정보0%부채/자본 비율CA$0부채이자보상배율n/a현금CA$128.60k자본-CA$302.38k총부채CA$431.08k총자산CA$128.71k최근 재무 건전성 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • May 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$133k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$133k free cash flow). Negative equity (-CA$302k). Revenue is less than US$1m. Market cap is less than US$10m (CA$348.1k market cap, or US$255.5k).Board Change • Jan 19No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Elmar Prenner is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.공지 • Jan 12FluroTech Ltd. Announces Chief Financial Officer ChangesFluroTech Ltd. announced that effective October 6, 2025, Reem Chalhoub has been appointed as the new Chief Financial Officer. Reem Chalhoub succeeds Curtis Smith, who has departed the Company. Reem Chalhoub is a seasoned accountant with over 10 years of executive financial leadership. As a strategic financial leader, she has successfully secured more than $50 million in financing and led private equity business buyouts, bringing deep expertise in M&A transactions, investor relations, and corporate restructuring. Reem launched her career at PwC, where she worked with multinational corporations such as Bayer and Ford, contributing to large-scale audits and complex public financial reporting. She later served as the Head of Corporate Finance at Ecolab Canada, driving strategic financial initiatives at a national level. Reem offers CFO services, partnering with CEOs and investors to craft and execute high-impact financial strategies. Her ability to scale businesses and optimize financial performance makes her a trusted advisor to growth-focused companies.공지 • Jun 14Flurotech Ltd. Appoints Eric Corbett to Board of Directors, Effective June 12, 2025FluroTech Ltd. announce that effective June 12, 2025, Eric Corbett has been appointed to the board of directors. Mr. Corbett is the Managing Director of Oakridge Securities Inc. which operates as a capital markets and corporate finance advisory business, where he has been employed since December 2024. From August 2017 to September 2024, Mr. Corbett was part of the corporate client group at Canadian Imperial Bank of Commerce, one of Canada's largest financial institutions, where he oversaw the execution of high-profile transactions, including providing debt capital to private and public businesses to support M&A transactions, shareholder buyouts, working capital support and sponsor backed equity investments. Mr. Corbett has served as a board member of Entero Therapeutics Inc. since February 2025 and Mixed Martial Arts Group Limited (NYSE: MMA) since April 2025. Mr. Corbett holds a Bachelor of Commerce degree from McMaster University and is also a CFA charterholder. Mr. Corbett has successfully completed the FINRA Securities Industry Essentials Exam, the CSI Canadian Securities Course and the CSI Conduct & Practices Handbook. Mr. Corbett is well qualified to serve on the board due to his specialization in capital allocation and corporate finance.공지 • May 03FluroTech Ltd. announced that it expects to receive CAD 22 million in fundingFluroTech Ltd. announced a best effort basis private placement of 5,500,000 subscription receipts at a price of CAD 4 per share for the gross proceeds of CAD 22,000,000 on May 1, 2024. The transaction is expected to be completed in Q2 2024.공지 • Mar 22FluroTech Ltd., Annual General Meeting, May 17, 2024FluroTech Ltd., Annual General Meeting, May 17, 2024.공지 • Mar 12FluroTech Ltd. announced that it expects to receive CAD 1 million in fundingFluroTech Ltd. announced a private placement of minimum of 6,666,667 common shares at an issue price of CAD 0.075 per share for minimum gross proceeds of CAD 500,000.025 and maximum of 13,333,333 common shares at an issue price of CAD 0.075 per share for maximum gross proceeds of CAD 999,999.975 on March 11, 2024. The financing remains subject to TSXV approval.공지 • Dec 22+ 1 more updateFluroTech Ltd. announced that it expects to receive CAD 1 million in fundingFluroTech Ltd. announces private placement of 5,000,000 shares at an issue price of CAD 0.10 per share for minimum gross proceeds of CAD 500,000 to 10,000,000 common shares at an issue price of CAD 0.10 per share for maximum gross proceeds of CAD 1,000,000 on December 21, 2023. The financing is subject to the approval of the TSXV stock exchange.공지 • Jan 14FluroTech Ltd., Annual General Meeting, Mar 20, 2023FluroTech Ltd., Annual General Meeting, Mar 20, 2023.공지 • Jan 04An unknown individual buyer acquired FluroTest Systems Ltd from FluroTech Ltd. for CAD 1.An unknown individual buyer acquired FluroTest Diagnostic Systems Ltd. from FluroTech Ltd. for CAD 1 on December 31, 2022. An unknown individual buyer completed the acquisition of FluroTest Diagnostic Systems Ltd. from FluroTech Ltd. on December 31, 2022.Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Independent Director Brendan Miles is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Is New 90 Day High Low • Feb 23New 90-day high: CA$0.70The company is up 352% from its price of CA$0.15 on 24 November 2020. The Canadian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 43% over the same period.Is New 90 Day High Low • Feb 04New 90-day high: CA$0.60The company is up 216% from its price of CA$0.19 on 05 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 42% over the same period.Is New 90 Day High Low • Jan 15New 90-day high: CA$0.32The company is up 24% from its price of CA$0.26 on 16 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 20% over the same period.재무 상태 분석단기부채: TEST.H 에는 음의 주주 지분이 있는데, 이는 단기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.장기 부채: TEST.H는 마이너스 주주 지분을 갖고 있어 장기 부채를 충당하지 못하는 단기 자산보다 더 심각한 상황입니다.부채/자본 비율 추이 및 분석부채 수준: TEST.H 부채가 없습니다.부채 감소: TEST.H는 주주 지분이 음수이므로 부채가 시간이 지남에 따라 감소했는지 확인할 필요가 없습니다.대차대조표현금 보유 기간 분석과거에 평균적으로 손실을 기록해 온 기업의 경우, 최소 1년 이상의 현금 보유 기간이 있는지 평가합니다.안정적인 현금 활주로: TEST.H 현재 무료 현금 흐름을 기준으로 1년 미만의 cash runway를 보유하고 있습니다.예측 현금 활주로: 무료 현금 흐름이 매년 40.4 %의 역사적 비율로 계속 증가할 경우 TEST.H 의 현금 활주로는 1년 미만입니다.건전한 기업 찾아보기7D1Y7D1Y7D1YTech 산업의 건실한 기업.View Dividend기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/10 09:04종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FluroTech Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • May 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$133k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$133k free cash flow). Negative equity (-CA$302k). Revenue is less than US$1m. Market cap is less than US$10m (CA$348.1k market cap, or US$255.5k).
Board Change • Jan 19No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Elmar Prenner is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
공지 • Jan 12FluroTech Ltd. Announces Chief Financial Officer ChangesFluroTech Ltd. announced that effective October 6, 2025, Reem Chalhoub has been appointed as the new Chief Financial Officer. Reem Chalhoub succeeds Curtis Smith, who has departed the Company. Reem Chalhoub is a seasoned accountant with over 10 years of executive financial leadership. As a strategic financial leader, she has successfully secured more than $50 million in financing and led private equity business buyouts, bringing deep expertise in M&A transactions, investor relations, and corporate restructuring. Reem launched her career at PwC, where she worked with multinational corporations such as Bayer and Ford, contributing to large-scale audits and complex public financial reporting. She later served as the Head of Corporate Finance at Ecolab Canada, driving strategic financial initiatives at a national level. Reem offers CFO services, partnering with CEOs and investors to craft and execute high-impact financial strategies. Her ability to scale businesses and optimize financial performance makes her a trusted advisor to growth-focused companies.
공지 • Jun 14Flurotech Ltd. Appoints Eric Corbett to Board of Directors, Effective June 12, 2025FluroTech Ltd. announce that effective June 12, 2025, Eric Corbett has been appointed to the board of directors. Mr. Corbett is the Managing Director of Oakridge Securities Inc. which operates as a capital markets and corporate finance advisory business, where he has been employed since December 2024. From August 2017 to September 2024, Mr. Corbett was part of the corporate client group at Canadian Imperial Bank of Commerce, one of Canada's largest financial institutions, where he oversaw the execution of high-profile transactions, including providing debt capital to private and public businesses to support M&A transactions, shareholder buyouts, working capital support and sponsor backed equity investments. Mr. Corbett has served as a board member of Entero Therapeutics Inc. since February 2025 and Mixed Martial Arts Group Limited (NYSE: MMA) since April 2025. Mr. Corbett holds a Bachelor of Commerce degree from McMaster University and is also a CFA charterholder. Mr. Corbett has successfully completed the FINRA Securities Industry Essentials Exam, the CSI Canadian Securities Course and the CSI Conduct & Practices Handbook. Mr. Corbett is well qualified to serve on the board due to his specialization in capital allocation and corporate finance.
공지 • May 03FluroTech Ltd. announced that it expects to receive CAD 22 million in fundingFluroTech Ltd. announced a best effort basis private placement of 5,500,000 subscription receipts at a price of CAD 4 per share for the gross proceeds of CAD 22,000,000 on May 1, 2024. The transaction is expected to be completed in Q2 2024.
공지 • Mar 22FluroTech Ltd., Annual General Meeting, May 17, 2024FluroTech Ltd., Annual General Meeting, May 17, 2024.
공지 • Mar 12FluroTech Ltd. announced that it expects to receive CAD 1 million in fundingFluroTech Ltd. announced a private placement of minimum of 6,666,667 common shares at an issue price of CAD 0.075 per share for minimum gross proceeds of CAD 500,000.025 and maximum of 13,333,333 common shares at an issue price of CAD 0.075 per share for maximum gross proceeds of CAD 999,999.975 on March 11, 2024. The financing remains subject to TSXV approval.
공지 • Dec 22+ 1 more updateFluroTech Ltd. announced that it expects to receive CAD 1 million in fundingFluroTech Ltd. announces private placement of 5,000,000 shares at an issue price of CAD 0.10 per share for minimum gross proceeds of CAD 500,000 to 10,000,000 common shares at an issue price of CAD 0.10 per share for maximum gross proceeds of CAD 1,000,000 on December 21, 2023. The financing is subject to the approval of the TSXV stock exchange.
공지 • Jan 14FluroTech Ltd., Annual General Meeting, Mar 20, 2023FluroTech Ltd., Annual General Meeting, Mar 20, 2023.
공지 • Jan 04An unknown individual buyer acquired FluroTest Systems Ltd from FluroTech Ltd. for CAD 1.An unknown individual buyer acquired FluroTest Diagnostic Systems Ltd. from FluroTech Ltd. for CAD 1 on December 31, 2022. An unknown individual buyer completed the acquisition of FluroTest Diagnostic Systems Ltd. from FluroTech Ltd. on December 31, 2022.
Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Independent Director Brendan Miles is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Is New 90 Day High Low • Feb 23New 90-day high: CA$0.70The company is up 352% from its price of CA$0.15 on 24 November 2020. The Canadian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 43% over the same period.
Is New 90 Day High Low • Feb 04New 90-day high: CA$0.60The company is up 216% from its price of CA$0.19 on 05 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 42% over the same period.
Is New 90 Day High Low • Jan 15New 90-day high: CA$0.32The company is up 24% from its price of CA$0.26 on 16 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 20% over the same period.